David Cronin

David Cronin

Clash Over World Customs Organization Efforts On IP Enforcement

By David Cronin for Intellectual Property Watch BRUSSELS – Developing countries this week clashed with senior officials in the World Customs Organisation over an initiative designed to ensure that intellectual property rights are upheld at border posts, according to participants.…

EPO Head Sees Need To Review IP Rules For Climate Change

By David Cronin for Intellectual Property Watch
BRUSSELS - Changes to intellectual property rules may be needed to facilitate the use of technology aimed at addressing climate change, the head of the European Patent Office (EPO) has suggested.

Next month, the 34-country EPO will host what it claims is the first major international conference to examine the patenting issues raised by global warming.

Alison Brimelow, the EPO's president, said the European Patent Forum in the Slovenian capital Ljubljana will give an opportunity to exchange ideas on whether the international system for regulating intellectual property should be modified.

Policymaking On Trade And IP Faces Mixed Prospects In 2008

By David Cronin for Intellectual Property Watch
With America's political elite fixated on the race for the White House, the likelihood that the world's most powerful country will make much progress during 2008 in free trade negotiations with other nations appears slim.

Across the Atlantic, however, European Union officials have indicated they will be vigorous in insisting that high standards for protecting intellectual property are upheld as universally as possible. Numerous other bilateral talks are ongoing around the world as well. And attention may be drawn from the longstanding trade negotiations at the World Trade Organization.

EU Acceptance Of TRIPS Health Amendment Adds 28 Members

By David Cronin for Intellectual Property Watch The European Union has taken steps to ratify a 2005 decision by the World Trade Organization designed to ensure that intellectual property does not limit access to medicines in developing countries. Peter Mandelson,…